The companies’ new effort would bypass traditional middlemen to cut the drug’s monthly cost from a list price of around $606 ...

(Reuters) -Bristol Myers and Pfizer said on Thursday they will start selling their blockbuster blood thinner, Eliquis, ...

Drugmakers will offer Eliquis at a 43% discount to uninsured U.S. patients, bypassing insurers and PBMs New $346 monthly ...

The discounted price is 40% lower than the US list price, Bristol said, but it’s higher than the one the Biden administration ...

Bristol-Myers Squibb (BMY) and Pfizer (PFE) will offer a 40% discount on Eliquis, a blood thinner, starting September 8th, through a direct-to-consumer service, WSJ reported on Thursday.

The direct-to-consumer (DTC) platform – called Eliquis 360 Support – will offer Eliquis (apixaban) to patients who pay for ...

In advance of CMS’ negotiated price for the blood thinner taking effect next year, partners Bristol Myers Squibb and Pfizer ...

A direct-to-consumer program for its drugs could bring down higher U.S. drug prices while cutting out pharmacy benefit managers.

Roche (RHHBY) plans direct-to-patient drug sales in the U.S. to avoid the influence from pharmacy benefit managers in product ...

Chemist Warehouse is set to create dozens of jobs as the company opens its first Limerick store this weekend. The 6,460-square-foot store marks the company’s 15th location in Ireland and brings 24 new ...

Roche is considering selling its prescription medicines in the U.S. directly to consumers to lower costs for patients as part of talks with the U.S. government, which is pressuring drugmakers to cut ...